Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol and Air Pollution in Asthmatics
NCT02252302Completed
- Sponsor
- University of British Columbia
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of salbutamol in asthma (8 arms), sponsored by University of British Columbia. Primary endpoint: Change in rating of perceived exertion for breathing, dyspnea. Started May 2015; status: completed.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02252302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02252302.